A team led by Eamon Doyle, Ph.D., in the Borzage Laboratory at Children's Hospital Los Angeles developed novel computational models for magnetic resonance imaging. These models enable more accurate ...
Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to - or even replacing - gadolinium-based MRI agents A manganese-based MRI contrast agent could ...
Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
A twist on magnetic resonance imaging that does not require gadolinium contrast appears to be as effective as standard imaging at detecting prostate cancers, according to a new study in JAMA. Experts ...
Italy-based Bracco Imaging and Subtle Medical have obtained an EU CE mark for AiMIFY, a jointly developed software designed to enhance the imaging of contrast MRI brain scans using artificial ...
When doctors and scientists want to see inside a body, magnetic resonance imaging (MRI) is a powerful tool. MRI can noninvasively capture detailed images of the body's muscles, organs, and bones. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results